Telemedicine Use Increased Considerably During COVID-19Last Updated: February 01, 2021. Considerable Increase in Telemedicine Use During COVID-19
MONDAY, Feb. 1, 2021 (HealthDay News) -- Telemedicine use increased considerably during the COVID-19 pandemic, with lower use in communities with higher rates of poverty, according to a study published in the February issue of Health Affairs.
Sadiq Y. Patel, Ph.D., from Harvard Medical School in Boston, and colleagues examined variation in total outpatient visits and telemedicine use across patient demographics, specialties, and conditions among 16.7 million commercially insured and Medicare Advantage enrollees from January to June 2020.
The researchers found that 30.1 percent of all visits during the pandemic were provided via telemedicine, and there was a 23-fold increase in the weekly number of visits compared with the prepandemic period. Communities with higher rates of poverty had lower telemedicine use (31.9 versus 27.9 percent for lowest versus highest quartiles of poverty rate). Across specialties, there was variation in the use of any telemedicine during the pandemic, from 68 to 9 percent for endocrinologists and ophthalmologists, respectively. Across common conditions, there was variation noted in the percentage of visits provided via telemedicine during the pandemic, from 53 to 3 percent for depression and glaucoma, respectively. For common conditions, higher rates of telemedicine use were associated with smaller decreases in total weekly visits during the pandemic.
"Telemedicine use during COVID-19 varied across different clinical settings and patient populations, with lower use found among insurance enrollees in disadvantaged areas," the authors write. "Future research is needed to understand the persistence of these trends over longer periods and the impact of these changes on patients' health."
|Previous: WHO Team Probing COVID-19 Origins Visits Wuhan Food Markets||Next: Rifaximin Prevents Overt Hepatic Encephalopathy After TIPS|
Reader comments on this article are listed below. Review our comments policy.